Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Associations of Depressive Symptoms with Subjective Cognitive Decline in Elderly People-A Cross-Sectional Analysis from the AgeWell.de-Study.
Zöllinger I, Bauer A, Blotenberg I, Brettschneider C, Buchholz M, Czock D, Döhring J, Escales C, Fankhaenel T, Frese T, Hoffmann W, Kaduszkiewicz H, König HH, Luppa M, Oey A, Pabst A, Sanftenberg L, Thyrian JR, Weiss J, Wendel F, Wiese B, Riedel-Heller SG, Gensichen J. Zöllinger I, et al. Among authors: czock d. J Clin Med. 2023 Aug 10;12(16):5205. doi: 10.3390/jcm12165205. J Clin Med. 2023. PMID: 37629244 Free PMC article.
AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.
Zülke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J, Kaduszkiewicz H, König HH, Haefeli WE, Czock D, Wiese B, Frese T, Röhr S, Riedel-Heller SG. Zülke A, et al. Among authors: czock d. BMC Geriatr. 2019 Aug 1;19(1):203. doi: 10.1186/s12877-019-1212-1. BMC Geriatr. 2019. PMID: 31370792 Free PMC article. Clinical Trial.
Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
Röhr S, Zülke A, Luppa M, Brettschneider C, Weißenborn M, Kühne F, Zöllinger I, Samos FZ, Bauer A, Döhring J, Krebs-Hein K, Oey A, Czock D, Frese T, Gensichen J, Haefeli WE, Hoffmann W, Kaduszkiewicz H, König HH, Thyrian JR, Wiese B, Riedel-Heller SG. Röhr S, et al. Among authors: czock d. Int J Environ Res Public Health. 2021 Jan 7;18(2):408. doi: 10.3390/ijerph18020408. Int J Environ Res Public Health. 2021. PMID: 33430189 Free PMC article. Clinical Trial.
Social Network and Participation in Elderly Primary Care Patients in Germany and Associations with Depressive Symptoms-A Cross-Sectional Analysis from the AgeWell.de Study.
Wendel F, Bauer A, Blotenberg I, Brettschneider C, Buchholz M, Czock D, Döhring J, Escales C, Frese T, Hoffmann W, Kaduszkiewicz H, König HH, Löbner M, Luppa M, Schwenker R, Thyrian JR, Weißenborn M, Wiese B, Zöllinger I, Riedel-Heller SG, Gensichen J. Wendel F, et al. Among authors: czock d. J Clin Med. 2022 Oct 8;11(19):5940. doi: 10.3390/jcm11195940. J Clin Med. 2022. PMID: 36233810 Free PMC article.
Association of mental demands in the workplace with cognitive function in older adults at increased risk for dementia.
Zülke AE, Luppa M, Röhr S, Weißenborn M, Bauer A, Samos FZ, Kühne F, Zöllinger I, Döhring J, Brettschneider C, Oey A, Czock D, Frese T, Gensichen J, Haefeli WE, Hoffmann W, Kaduszkiewicz H, König HH, Thyrian JR, Wiese B, Riedel-Heller SG. Zülke AE, et al. Among authors: czock d. BMC Geriatr. 2021 Dec 10;21(1):688. doi: 10.1186/s12877-021-02653-5. BMC Geriatr. 2021. PMID: 34893023 Free PMC article.
Physical Activity Determinants in Older German Adults at Increased Dementia Risk with Multimorbidity: Baseline Results of the AgeWell.de Study.
Cardona MI, Weißenborn M, Zöllinger I, Kroeber ES, Bauer A, Luppa M, Pabst A, Czock D, König HH, Wiese B, Gensichen J, Frese T, Kaduszkiewicz H, Hoffmann W, Riedel-Heller SG, Thyrian JR. Cardona MI, et al. Among authors: czock d. Int J Environ Res Public Health. 2022 Mar 8;19(6):3164. doi: 10.3390/ijerph19063164. Int J Environ Res Public Health. 2022. PMID: 35328854 Free PMC article.
Perpetrator effects of ciclosporin (P-glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers.
Brings A, Lehmann ML, Foerster KI, Burhenne J, Weiss J, Haefeli WE, Czock D. Brings A, et al. Among authors: czock d. Br J Clin Pharmacol. 2019 Jul;85(7):1528-1537. doi: 10.1111/bcp.13934. Epub 2019 May 9. Br J Clin Pharmacol. 2019. PMID: 30912163 Free PMC article. Clinical Trial.
113 results